サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542809

血小板凝集装置の世界市場

Platelet Aggregation Devices

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血小板凝集装置の世界市場
出版日: 2024年08月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血小板凝集装置の世界市場は2030年までに8億8,850万米ドルに達する見込み

2023年に6億2,980万米ドルと推定された血小板凝集装置の世界市場は、2030年には8億8,850万米ドルに達し、分析期間2023-2030年のCAGRは5.0%で成長すると予測されます。本レポートで分析したセグメントの1つである血小板凝集システムは、CAGR 6.0％を記録し、分析期間終了までに4億6,540万米ドルに達すると予測されます。血小板凝集試薬セグメントの成長率は、分析期間中CAGR 4.2％と推定されます。

米国市場は1億6,980万米ドルと推定、中国はCAGR4.7％で成長すると予測

米国の血小板凝集装置市場は、2023年に1億6,980万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 4.7%で推移し、2030年には1億3,930万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.6%と4.2%と予測されています。欧州では、ドイツがCAGR 3.6%で成長すると予測されています。

世界の血小板凝集装置市場- 主要動向と促進要因のまとめ

血小板凝集の理解：専用デバイスの役割

血小板凝集装置は、血液中の血小板機能を評価するために設計された高度な医療機器であり、出血性疾患の診断や抗血小板療法の有効性のモニタリングに極めて重要です。これらの装置は、血小板が様々な作動薬に反応して凝集する程度を測定し、血栓形成の自然なプロセスをシミュレートします。主なメカニズムとしては、血液サンプルを採取し、それを血小板凝集を誘導する特定の試薬にさらします。この装置は、血小板が凝集する際の光透過率や電気インピーダンスの変化を記録し、血小板の機能性に関する定量的データを提供します。この情報は、臨床医が血小板減少症、ヴォン・ヴィレブランド病、その他の血小板機能障害などの病態を診断し、抗凝固療法を受けている患者の治療計画を調整するために不可欠です。

血小板凝集装置は医療現場でどのように活用されていますか？

臨床現場において、血小板凝集装置は診断と治療管理の両面で重要な役割を果たしています。血液専門医は、血小板の異常な挙動を確認することにより、遺伝性または後天性の血小板機能障害を診断するためにこのデバイスを使用します。心臓専門医や血管外科医は、血管形成術やステント留置術を受けた患者のアスピリンやクロピドグレルなどの抗血小板薬の有効性を評価するために血小板凝集検査を利用しています。このモニタリングは、過剰な凝固や出血によって引き起こされる心臓発作や脳卒中などの有害事象を予防するために不可欠です。さらに、血小板凝集検査は出血リスクを測定するための手術前の評価や、血小板機能を標的とした新しい治療薬を開発するための進行中の研究にも利用されています。正確で信頼性の高いデータを提供することで、これらの機器はヘルスケアプロバイダーが十分な情報に基づいた決定を下し、患者の転帰を向上させるのに役立っています。

血小板凝集デバイス技術の現在の動向は？

血小板凝集装置を支える技術は、より正確で効率的、そして使いやすい診断ツールへのニーズによって、絶えず進歩しています。重要な動向の一つは、迅速かつ分散化された検査を可能にするポイントオブケア検査装置の開発であり、これにより救急外来や小規模クリニックなど様々なヘルスケア環境において血小板機能評価がより身近なものとなっています。自動化と検査情報システムとの統合もまた増加傾向にあり、シームレスなデータ転送を可能にし、手作業によるミスを減らしています。さらに、先進的なソフトウェア・アルゴリズムの導入は、検査結果の解釈を強化し、より詳細で実用的な洞察を臨床医に提供します。もう一つの新たな動向は、検査プロセスを小型化し、必要な血液サンプル量を削減するマイクロ流体技術やラボオンチップ技術の使用です。これらの技術革新は、使いやすさを向上させ、所要時間を短縮し、血小板機能検査の精度を高めることで、臨床現場での応用と有用性を広げることを目的としています。

血小板凝集装置市場の成長を促進する要因は？

血小板凝集装置市場の成長は、ヘルスケアにおける正確で信頼性の高い診断ツールに対する需要の高まりを反映した、いくつかの要因によって牽引されています。抗血小板療法の慎重なモニタリングを必要とする心血管疾患の有病率の上昇は、重要な促進要因です。携帯型や自動化された装置の開発などの技術の進歩は、血小板機能検査へのアクセス性と効率性を高めています。出血性疾患に対する意識の高まりや、タイムリーな診断と管理の重要性も、市場の成長を後押ししています。さらに、新興国におけるヘルスケア・インフラの拡大により、高度な診断技術へのアクセスが増加しています。機器の精度と機能性の向上を目指した継続的な研究開発は、市場の拡大をさらに後押ししています。これらの要因が総合的に血小板凝集装置市場の堅調な成長を保証し、現代の医療診断と患者ケアにおける血小板凝集装置の重要な役割を浮き彫りにしています。

調査対象企業の例（全46件）

  • Aggredyne, Inc.
  • Bio/Data Corporation
  • F. Hoffmann-La Roche AG
  • Helena Laboratories Corporation
  • SENTINEL CH. SpA
  • Siemens AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP14028

Global Platelet Aggregation Devices Market to Reach US$888.5 Million by 2030

The global market for Platelet Aggregation Devices estimated at US$629.8 Million in the year 2023, is expected to reach US$888.5 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Platelet Aggregation Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$465.4 Million by the end of the analysis period. Growth in the Platelet Aggregation Reagents segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$169.8 Million While China is Forecast to Grow at 4.7% CAGR

The Platelet Aggregation Devices market in the U.S. is estimated at US$169.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$139.3 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Platelet Aggregation Devices Market - Key Trends and Drivers Summarized

Understanding Platelet Aggregation: The Role of Specialized Devices

Platelet aggregation devices are sophisticated medical instruments designed to assess the platelet function in blood, crucial for diagnosing bleeding disorders and monitoring the efficacy of antiplatelet therapy. These devices measure the extent to which platelets clump together in response to various agonists, which simulate the natural process of clot formation. The primary mechanism involves drawing a blood sample, which is then exposed to specific reagents that induce platelet aggregation. The device records changes in light transmission or electrical impedance as platelets aggregate, providing quantitative data on the functionality of platelets. This information is vital for clinicians to diagnose conditions like thrombocytopenia, von Willebrand disease, and other platelet function disorders, and to tailor treatment plans for patients on anticoagulant therapies.

How Are Platelet Aggregation Devices Utilized in Medical Practice?

In clinical settings, platelet aggregation devices play a crucial role in both diagnostics and treatment management. Hematologists use these devices to diagnose inherited or acquired platelet function disorders by identifying abnormal platelet behavior. Cardiologists and vascular surgeons rely on platelet aggregation tests to evaluate the effectiveness of antiplatelet medications, such as aspirin and clopidogrel, in patients who have undergone procedures like angioplasty or stent placement. This monitoring is essential to prevent adverse events such as heart attacks or strokes caused by either excessive clotting or bleeding. Additionally, platelet aggregation tests are utilized in pre-surgical assessments to gauge bleeding risk and in ongoing research to develop new therapeutic agents targeting platelet function. By providing precise and reliable data, these devices help healthcare providers make informed decisions that enhance patient outcomes.

What Are the Current Trends in Platelet Aggregation Device Technology?

The technology behind platelet aggregation devices is continually advancing, driven by the need for more accurate, efficient, and user-friendly diagnostic tools. One significant trend is the development of point-of-care testing devices that allow for rapid and decentralized testing, making platelet function assessment more accessible in various healthcare settings, including emergency rooms and small clinics. Automation and integration with laboratory information systems are also on the rise, enabling seamless data transfer and reducing manual errors. Additionally, the incorporation of advanced software algorithms enhances the interpretation of test results, providing clinicians with more detailed and actionable insights. Another emerging trend is the use of microfluidics and lab-on-a-chip technologies, which miniaturize the testing process and reduce the required blood sample volume. These innovations are aimed at improving the ease of use, reducing turnaround times, and increasing the accuracy of platelet function tests, thereby broadening their application and utility in clinical practice.

What Factors Are Driving the Growth in the Platelet Aggregation Devices Market?

The growth in the platelet aggregation devices market is driven by several factors, reflecting the increasing demand for precise and reliable diagnostic tools in healthcare. The rising prevalence of cardiovascular diseases, which require careful monitoring of antiplatelet therapy, is a significant driver. Advances in technology, such as the development of portable and automated devices, are enhancing the accessibility and efficiency of platelet function testing. The growing awareness of bleeding disorders and the importance of timely diagnosis and management are also propelling market growth. Additionally, the expansion of healthcare infrastructure in emerging economies is increasing access to advanced diagnostic technologies. The continuous research and development efforts aimed at improving device accuracy and functionality further support market expansion. These factors collectively ensure robust growth in the platelet aggregation devices market, highlighting their essential role in modern medical diagnostics and patient care.

Select Competitors (Total 46 Featured) -

  • Aggredyne, Inc.
  • Bio/Data Corporation
  • F. Hoffmann-La Roche AG
  • Helena Laboratories Corporation
  • SENTINEL CH. SpA
  • Siemens AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Platelet Aggregation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Platelet Aggregation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Accessories & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Accessories & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 16: World 7-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 17: World Platelet Aggregation Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • JAPAN
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • CHINA
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: China 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • EUROPE
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 43: Europe 7-Year Perspective for Platelet Aggregation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • FRANCE
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: France 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • GERMANY
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Germany 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Italy 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • UNITED KINGDOM
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: UK 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World 7-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2024 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Rest of World 7-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2024 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of World 7-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2024 & 2030

IV. COMPETITION